TP53 and cancer: Because phosphorylated or activated AKT enhance survival and inhibit apoptosis by inactivation of target proteins, including the proapoptotic BAD and the tumor suppressor p53 [26,27], AKT is a potentially important FAK effector molecule for cancer cell survival.